Abstract
Aims:
To determine whether general practitioners (GPs) distinguish between the management of acute rhinosinusitis (ARS) and chronic rhinosinusitis (CRS), especially with regard to prescription of antibiotics and nasal steroids.
Methods:
A questionnaire on the management of rhinosinusitis was sent to 1000 GPs in the Netherlands.
Results:
Ninety-six percent discriminated between ARS and CRS. However, the definition of ARS and CRS varied. The percentage of GPs prescribing antibiotics rose as rhinosinusitis severity increased. The prescription rate of nasal corticosteroids was highest for CRS (88.6%). Prescribing nasal corticosteroids in ARS was not very common.
Conclusions:
Most GPs discriminate between ARS and CRS and 54% accepted (the EP3OS-defined) 12 weeks as the division between ARS and CRS. Antibiotics and nasal steroids are commonly used agents, but the management of rhinosinusitis is not always consistent with guidelines.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
There are no conflicts of interest.
Rights and permissions
About this article
Cite this article
Hoffmans, R., Schermer, T., van Weel, C. et al. Management of rhinosinusitis in Dutch general practice. Prim Care Respir J 20, 64–70 (2011). https://doi.org/10.4104/pcrj.2010.00064
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4104/pcrj.2010.00064
This article is cited by
-
Common Cold and Acute Rhinosinusitis: Up-to-Date Management in 2020
Current Allergy and Asthma Reports (2020)
-
Rhinosinusitis in morbidity registrations in Dutch General Practice: a retro-spective case-control study
BMC Family Practice (2015)